Cutaneous and Gastrointestinal Leukocytoclastic Vasculitis Induced by Palbociclib in a Metastatic Breast Cancer Patient: A Case Report

被引:9
作者
Guillemois, Sylvere [1 ]
Patsouris, Anne [1 ]
Peyraga, Guillaume [2 ]
Chassain, Kevin [3 ]
Le Corre, Yannick [3 ]
Campone, Mario [1 ]
Augereau, Paule [1 ]
机构
[1] Ctr Paul Papin, Med Oncol Dept, Inst Cancerol Ouest, Angers, France
[2] Ctr Paul Papin, Radiat Therapy Dept, Inst Cancerol Ouest, Angers, France
[3] Univ Hosp Angers, Dermatol Dept, Angers, France
关键词
Cyclin-dependent kinase 4/6 inhibitor; Drug-induced vasculitis; Faslodex; Fulvestrant; Ibrance; Vasculitis treatment; RANDOMIZED CONTROLLED-TRIAL; THERAPY; LETROZOLE;
D O I
10.1016/j.clbc.2018.07.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The efficacy and safety of palbociclib, a cyclindependent kinase 4/6 inhibitor, used in combination with fulvestrant was assessed in women with advanced breast cancer (ABC) whose disease had progressed during previous endocrine therapy, with a significant improvement of progression-free survival and good health-related quality of life. We report a case of an 80-year-old patient with ABC who presented a cutaneous and gastrointestinal vasculitis during treatment with palbociclib and fulvestrant. The skin biopsy was consistent with a leukocytoclastic vasculitis with immunoglobulin A deposits in dermal blood vessels. The symptoms disappeared with the arrest of palbociclib and fulvestrant treatment and a high dose corticotherapy. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:E755 / E758
页数:4
相关论文
共 50 条
  • [21] Gastrointestinal metastatic breast cancer unmasked by anticoagulation
    Joy, Jiss
    Nelson, Alexander
    Potter, David
    Beckman, Joan D.
    CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2020, 1
  • [22] Necrotizing leukocytoclastic small vessel vasculitis associated with letrozole: A case report
    Mohaghegh, Fatemeh
    Bahrami, Bahareh
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2020, 58 (12) : 732 - 735
  • [23] Effect of Concurrent Proton Pump Inhibitors With Palbociclib Tablets for Metastatic Breast Cancer
    Schieber, Timothy
    Steele, Samantha
    Collins, Stephanie
    Berger, Michael
    Fleming, Megan
    Mclaughlin, Eric
    Sudheendra, Preeti
    Vargo, Craig
    CLINICAL BREAST CANCER, 2023, 23 (06) : 658 - 663
  • [24] Palbociclib added to ongoing endocrine therapy for hormone receptor-positive HER2-negative metastatic breast cancer: A case report series
    Schettini, Francesco
    De Santo, Irene
    Rea, Carmen G.
    Viggiani, Martina
    Buono, Giuseppe
    De Angelis, Carmine
    Cardalesi, Cinzia
    Lauria, Rossella
    Giuliano, Mario
    Forestieri, Valeria
    Thomas, Guglielmo
    Maione, Pierfrancesco
    Limite, Gennaro
    Accurso, Antonello
    Malorni, Luca
    De Placido, Sabino
    Arpino, Grazia
    MOLECULAR AND CLINICAL ONCOLOGY, 2020, 12 (05) : 456 - 460
  • [25] Tolerability and effectiveness of palbociclib in older women with metastatic breast cancer
    Baltussen, Joosje C.
    Mooijaart, Simon P.
    Vulink, Annelie J. E.
    Houtsma, Danny
    van der Deure, Wendy M.
    Westerman, Elsbeth M.
    Oosterkamp, Hendrika M.
    Spierings, Leontine E. A. M. M.
    van den Bos, Frederiek
    de Glas, Nienke A.
    Portielje, Johanneke E. A.
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 206 (02) : 337 - 346
  • [26] Oncolytic virotherapy for metastatic breast cancer - a case report
    Gesundheit, Benjamin
    Muckenhuber, Alexander
    Posen, Yehudit
    Ellis, Ronald
    Zisman, Philip David
    Schmoll, Harald
    Weisslein, Christine
    Raju, Jayadeepa Srinivas
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [27] Palbociclib safety and efficacy beyond Ribociclib-induced liver toxicity in metastatic hormone-receptors positive breast cancer patient
    Farhat, Fadi
    Tarabaih, Mohammad
    Kanj, Ali
    Aoun, Majeda
    Kattan, Joseph
    Assi, Tarek
    Awada, Ahmad
    ANTI-CANCER DRUGS, 2020, 31 (01) : 85 - 89
  • [28] Atezolizumab-induced psoriasis in a patient with metastatic lung cancer-a case report
    Mao, Mien
    Shi, Min
    Li, Tao
    Wang, Qifeng
    Wu, Lei
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (05) : 3776 - 3782
  • [29] Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: a case report
    Minichillo, Santino
    Gallelli, Ilaria
    Barbieri, Elena
    Cubelli, Marta
    Rubino, Daniela
    Quercia, Sara
    Dall'Olio, Massimo
    Rapezzi, Claudio
    Zamagni, Claudio
    BMC CANCER, 2017, 17
  • [30] Treatment satisfaction in women receiving palbociclib combination therapies for advanced/metastatic breast cancer
    Darden, Christina
    Mitra, Debanjali
    McSorley, David
    Davis, Kimberly
    Band, Juliet
    Iyer, Shrividya
    FUTURE ONCOLOGY, 2019, 15 (02) : 141 - 150